Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli

被引:15
作者
Watanabe, Y
Hashizume, M
Kataoka, S
Hamaguchi, E
Morimoto, N
Tsuru, S
Katoh, S
Miyake, K
Matsushima, K
Tominaga, M
Kurashige, T
Fujimoto, S
Kincade, PW
Tominaga, A [1 ]
机构
[1] Kochi Med Sch, Dept Med Biol, Nankoku, Kochi 7838505, Japan
[2] Kochi Med Sch, Dept Pediat, Nankoku, Kochi 7838505, Japan
[3] Kochi Med Sch, Med Res Ctr, Nankoku, Kochi 7838505, Japan
[4] Kochi Med Sch, Radioisotope Ctr, Nankoku, Kochi 7838505, Japan
[5] Kochi Med Sch, Clin Lab, Nankoku, Kochi 7838505, Japan
[6] Kochi Med Sch, Dept Immunol, Nankoku, Kochi 7838505, Japan
[7] Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 88916, Japan
[8] Saga Med Sch, Dept Immunol, Saga, Japan
[9] Univ Tokyo, Sch Med, Dept Prevent Med, Tokyo 113, Japan
[10] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA
关键词
D O I
10.1089/104454901750219071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To characterize interleukin (IL)-5-induced eosinophils, we examined the expression of CD44, very late antigen (VLA)-4 and the IL-5 receptor alpha chain, as well as the levels of eosinophil peroxidase and the generation of superoxide. Eosinophils were prepared from IL-5-transgenic mice, then characterized using electron microscopy to determine their responses to stimuli. Whereas CD44 densities remained almost constant, the level of VLA-4 increased in parallel with eosinophil maturation. Although a subset of IL-5-induced eosinophils with high side scatter recovered from bone marrow and rare ones found in blood recognized hyaluronic acid (HA), most did not have this property, Bone marrow eosinophils with high side scatter and lower density contained eosinophil peroxidase, not only in granules, but also in membranous structures for 30% of this population. This population developed HA-binding ability in response to IL-3, IL-4, IL-5, granulocyte-macrophage colony-stimulating factor, macrophage inflammatory protein (MIP)-2, monocyte chemotactic protein (MCP)-1, eotaxin, nerve growth factor (NGF), and opsonized zymosan (OZ), Peripheral blood eosinophils acquired HA-binding ability in response to the same stimuli, but their responses were less than those of bone marrow eosinophils with high levels of side scatter. However, splenic eosinophils did not respond to these stimuli. Although peripheral blood eosinophils did not proliferate when stimulated by IL-5, these were the only cells that released eosinophil peroxidase in response to IL-4, MIP-2, MCP-1, eotaxin, NGF, and OZ. With the exception of a subset of bone marrow eosinophils? the ability to acquire HA binding, but not the ability to generate superoxide, correlated with eosinophil peroxidase activity and major basic protein accumulation in the granules of maturing cells.
引用
收藏
页码:189 / 202
页数:14
相关论文
共 57 条
  • [1] CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE
    ARUFFO, A
    STAMENKOVIC, I
    MELNICK, M
    UNDERHILL, CB
    SEED, B
    [J]. CELL, 1990, 61 (07) : 1303 - 1313
  • [2] BERMAN EL, 1983, SCAN ELECTRON MICROS, P311
  • [3] ADHESION OF HUMAN BASOPHILS, EOSINOPHILS, AND NEUTROPHILS TO INTERLEUKIN 1-ACTIVATED HUMAN VASCULAR ENDOTHELIAL-CELLS - CONTRIBUTIONS OF ENDOTHELIAL-CELL ADHESION MOLECULES
    BOCHNER, BS
    LUSCINSKAS, FW
    GIMBRONE, MA
    NEWMAN, W
    STERBINSKY, SA
    DERSEANTHONY, CP
    KLUNK, D
    SCHLEIMER, RP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) : 1553 - 1556
  • [4] EOSINOPHILIA IN TRANSGENIC MICE EXPRESSING INTERLEUKIN-5
    DENT, LA
    STRATH, M
    MELLOR, AL
    SANDERSON, CJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) : 1425 - 1431
  • [5] GABIG TG, 1978, J BIOL CHEM, V253, P6663
  • [6] GARTNER I, 1980, IMMUNOLOGY, V40, P133
  • [7] GRUBER MF, 1992, J IMMUNOL, V148, P1113
  • [8] Nerve growth factor enhances survival and cytotoxic activity of human eosinophils
    Hamada, A
    Watanabe, N
    Ohtomo, H
    Matsuda, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) : 299 - 302
  • [9] HAMANN KJ, 1995, J IMMUNOL, V154, P4073
  • [10] HATHCOCK KS, 1993, J IMMUNOL, V151, P6712